Psilocybin, Cancer and Depression

The HOPE trial (A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients with Cancer) is an Institutional Review Boards-approved open-label feasibility and safety pilot study examining psilocybin-assisted group therapy in cancer patients with a DSM-5 depressive disorder (including major depressive disorder as well as adjustment disorder with depressed mood).

This pilot study demonstrated the safety, feasibility, and possible efficacy of psilocybin-assisted group therapy for cancer patients dealing with depressive symptoms.

Read more

SSRI's and Psilocybin

New research from Compass Pathways says that:

“It has long been thought that SSRIs could interfere with the potential therapeutic effect of psilocybin.

This data is exciting because it provides a preliminary signal that this is not the case, and that patients could remain on their SSRI antidepressant medication and experience the same effect from COMP360 psilocybin treatment as people who are not on SSRIs.”

Read more

Massachusetts Joins the Psychedelic Legalization Effort!

Massachusetts may be the next state to legalize psychedelic use through a voter initiative.

The newly formed Massachusetts for Mental Health Options (MMHO) committee submitted initial documents to the state Office of Campaign and Political Finance (OCPF), signaling their intent to secure ballot placement for the measure, details of which are currently sparse.

Read more